Chemical screening using GL derivatives revealed that the glucoside derivative glucoglycyrrhizin (GlucoGL) binds more potently to PGRMC1 and contributes to the suppression of PGRMC1-mediated cancer chemoresistance. The gene discussed is PGRMC1; the disease is cancer.